The reported statements, read against the company's own industry.
Financials view
Market Capitalization
316.30MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue (TTM)
41.88MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
-292.68%
Updated Jul 18, 2026
Beta
0.3390x
vs all stocks
Updated Jul 18, 2026
52-Week Change
-51.95%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
316.30MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
340.38MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Forward P/E
-18.71x
Updated Jul 18, 2026
Price to Sales (TTM)
7.61x
Updated Jul 18, 2026
Price to Book (MRQ)
1.05x
Updated Jul 18, 2026
Enterprise to Revenue
8.13x
Updated Jul 18, 2026
Enterprise to EBITDA
-10.61x
Updated Jul 18, 2026
Gross Margin
3.25%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 72.7%.Updated Jul 18, 2026
Profit Margin
-292.68%
Updated Jul 18, 2026
Operating Margin
-906.03%
Updated Jul 18, 2026
Return on Assets (TTM)
-19.34%
Updated Jul 18, 2026
Return on Equity (TTM)
-81.24%
Updated Jul 18, 2026
Revenue (TTM)
41.88MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue per Share (TTM)
0.1480USDUpdated Jul 18, 2026
Quarterly Revenue Growth
443.10%
Updated Jul 18, 2026
Gross Profit (TTM)
30.44MUSD
vs all stocks (USD)
Updated Jul 18, 2026
EBITDA (TTM)
-32.09MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Net Income (TTM)
-122.56MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Quarterly Earnings Growth (YoY)
443.08%
Updated Jul 18, 2026
Operating Cash Flow (TTM)
-26.31MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Levered Free Cash Flow (TTM)
-99.15MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 18, 2026
Payout Ratio
0.00%
Updated Jul 18, 2026
Revenue
39.09MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
8.69MUSDFY2025 · Dec 31, 2025
Gross Profit
30.40MUSDFY2025 · Dec 31, 2025
Operating Income
-32.48MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-78.99MUSDFY2025 · Dec 31, 2025
Income Tax Expense
5.00KUSDFY2025 · Dec 31, 2025
Net Income
-78.99MUSDFY2025 · Dec 31, 2025
EBIT
-32.48MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-16.35MUSDFY2025 · Dec 31, 2025
Research & Development
16.50MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
46.38MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.5200USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.5200USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
152.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
152.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-78.99MUSDFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025
Operating Cash Flow
-53.70MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-54.08MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.00MUSDFY2025 · Dec 31, 2025
Income Tax Paid
4.00KUSDFY2025 · Dec 31, 2025
Interest Paid
874.00KUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-78.99MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
10.34MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
6.26MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
22.93MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-31.95MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
7.44MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
10.28MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-380.00KUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025
Net Acquisitions
-7.50MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-7.88MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
27.53MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-4.26MUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-1.32MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
2.50MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
29.47MUSDFY2025 · Dec 31, 2025
Shares Outstanding
617.81MSharesUpdated Jul 18, 2026
Float Shares
536.47MSharesUpdated Jul 18, 2026
Shares Short
96.68MSharesUpdated Jul 18, 2026
Short Ratio
3.50days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
15.84%
vs all stocks
Updated Jul 18, 2026
% Held by Insiders
37.45%
vs all stocks
Updated Jul 18, 2026
% Held by Institutions
4.43%
vs all stocks
Updated Jul 18, 2026
Total Cash (MRQ)
2.21MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Cash per Share (MRQ)
0.0030USDUpdated Jul 18, 2026
Total Debt (MRQ)
10.97MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Debt to Equity (MRQ)
0.0499x
Updated Jul 18, 2026
Current Ratio (MRQ)
4.62x
Updated Jul 18, 2026
Book Value per Share (MRQ)
0.3560USDUpdated Jul 18, 2026
Total Assets
274.70MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
142.87MUSDFY2025 · Dec 31, 2025
Total Liabilities
36.73MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
131.83MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
9.85MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
26.88MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.00MUSDFY2025 · Dec 31, 2025
Accounts Receivable
888.00KUSDFY2025 · Dec 31, 2025
Inventory
636.00KUSDFY2025 · Dec 31, 2025
Accounts Payable
10.83MUSDFY2025 · Dec 31, 2025
Short-term Debt
5.59MUSDFY2025 · Dec 31, 2025
Deferred Revenue
1.88MUSDFY2025 · Dec 31, 2025
Long-term Debt
5.92MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.92MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
59.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-377.44MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
237.97MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
0.2500USDUpdated Jul 18, 2026
52-Week High
4.10USDUpdated Jul 18, 2026
52-Week Change
-51.95%
vs all stocks
Updated Jul 18, 2026
Beta
0.3390x
vs all stocks
Updated Jul 18, 2026
50-Day MA
0.4362USDUpdated Jul 18, 2026
200-Day MA
1.01USDUpdated Jul 18, 2026
Avg 10-Day Volume
14.13MSharesUpdated Jul 18, 2026
Avg 30-Day Volume
23.97MSharesUpdated Jul 18, 2026
Diluted EPS (TTM)
-0.4300USDUpdated Jul 18, 2026
Other Income / Expense
-26.53MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.5: safe zoneNotable
Altman Z-Score: 3.50
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC